Scintigraphic visualization of ocular melanoma with Tc-99m glutathione

Annals of Nuclear Medicine

Volumn 11, Issue 2, 1997, Pages 143-146

  Tutuş, Ahmet ^a   Erkiliç, Kuddusi ^a   Ercan, Meral T ^b   Kontaş, Olgun ^a   Aydin, Mehmet ^b   Doǧan, Hakk ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

99mTc GSH; 99mTc sestamibi; Ocular melanoma

Indexed keywords

GLUTATHIONE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M;

ADULT; ARTICLE; CASE REPORT; CHOROID MELANOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030839440     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164823     Document Type: Article

References (21)

1. Thomas CI, Krohmer JS, Storaasli JP. Detection of intraocular tumors with radioactive phosphorus. Arch Ophtalmol 47: 276-286, 1952.
2. Beierwaltes WH, Varma VM, Liebermann LM, et al. Scintillation scanning of malignant melanomas with radioiodinated quinoline derivatives. J Lab Clin Med 12: 485-494, 1968.
3. Dencker L, Larsson B, Olander K, Ullberg S. A new melanoma seeker for possible clinical use: Selective accumulation of radiolabelled thiouracil. Br J Cancer 45: 95-104, 1982.
4. Holman BL, Wick MM, Kaplan ML, et al. The relationship of the eye uptake of N-isopropyl-p-[I-123]iodoamphetamine to melanin production. J Nucl Med 25: 315-319, 1984.
5. Ono S, Fukunaga M, Otsuka N, et al. Visualization of ocular melanoma with N-isopropyl-p-[I-123]-iodoamphetamine. J Nucl Med 29: 1448-1450, 1988.
6. 67Ga-citrate. Eur J Nucl Med 12: 96-104, 1986.
7. Bomanji J, Garner A, Prasad J, et al. Characterization of ocular melanoma with cutaneous melanoma antibodies. Br J Ophthal 71: 647-650, 1987.
8. 99mTc labelled cutaneous melanoma antibody fragments. Br J Ophthal 71: 651-658, 1987.
9. Scheidauer K, Markl A, Leinsinger MG, et al. lmmunoscintigraphy in intraocular malignant melanoma. Nucl Med Commun 9: 669-679, 1988.
10. Liewendahl K, Pyrḧnen S. Radioimmunodetection and radioimmunotherapy of malignant melanoma. Acta Oncologica 32: 717-721, 1993.
11. 99mTcglutathione in head and neck tumors. Nucl-Med 33: 224-228, 1994.
12. Duman Y, Burak Z, Ercan MT, et al. Clinical evaluation of metastases of malignant melanoma imaging with Tc-99m-glutathione and Tc-99m-anti-melanoma antibody: A comparative study. Nucl Med Commun 16: 927-935, 1995.
13. Abdel-Dayem HM, Scott AM, Macapinlac HA, et al. Role of TI-201 chloride and Tc-99m sestamibi in tumor imaging. In Freeman LM (ed.): Nuclear Medicine Annual 1994, New York, Raven Press Ltd., pp. 181-234, 1994.
14. Ercan MT, Bekdik CF, Şarizi T. Tc-99m-glutathione: labelling and distribution in rats. Int J Appl Rad Isotopes 29: 697-698, 1978.
15. Chakraborty AK, Ueda M, Mishima Y, Ichihashi M. Intracellular glutathione and its metabolizing enzyme activities in a metastatic variant melanoma cell line. Melanoma Res 2: 315-319, 1992.
16. Reed DJ. Regulation of reductive processes by glutathione. Biochem Pharmacol 35: 7-13, 1986.
17. Reed DJ. Glutathione: texicological implications. Ann Rev Pharmacol Toxicol 30: 603-631, 1990.
18. Reed DJ, Fariss MW. Glutathione depletion and susceptibility. Pharmacol Rev 36: 25-33, 1984.
19. 1-increased hepatocellular carcinomas by reduced glutathione. Science 212: 541-542, 1981.
20. Coates A, Tripp E. Glutathione content of human malignant melanoma cell lines: correlation of flow cytometric and biochemical assays and application to human tumor aspirates. Melanoma Res 1: 327-332, 1992.
21. Mannervik B, Castro VM, Danielson VH, et al. Expression of class Pi glutathione transferase in human malignant melanoma cells. Carcinogenesis 8: 1929-1932, 1987.